Cargando…

Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation

We tested whether loss of eukaryotic elongation factor 2 kinase (eEF2K) activity in macrophages suppresses development of atherosclerosis by transplanting bone marrow from mice with mutant eEF2K into ldlr(−/−) mice. Sixteen weeks after high-fat diet feeding, mutant eEF2K hematopoietic chimeras had a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peng, Riazy, Maziar, Gold, Matthew, Tsai, Shu-Huei, McNagny, Kelly, Proud, Christopher, Duronio, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pulsus Group 2014
Materias:	Brief Rapid Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424975/ https://www.ncbi.nlm.nih.gov/pubmed/25475470 http://dx.doi.org/10.1016/j.cjca.2014.09.019

Ejemplares similares

Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
por: Wang, Xuemin, et al.
Publicado: (2017)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Ruys, S. Pyr Dit, et al.
Publicado: (2012)

Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012)

A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
por: Xiao, Ting, et al.
Publicado: (2016)

Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule‐related proteins in neurons
por: Kenney, Justin W., et al.
Publicado: (2015)

Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains
por: Pigott, Craig R., et al.
Publicado: (2012)

Eukaryotic Elongation Factor 2 Kinase Activity Is Required for the Phenotypes of the Rpl24(Bst) Mouse
por: Knight, John R.P., et al.
Publicado: (2022)

CD103 in the development of experimental asthma
por: Blanchet, Marie-Renee, et al.
Publicado: (2010)

Induction of the Coxsackievirus and Adenovirus Receptor in Macrophages During the Formation of Atherosclerotic Plaques
por: Nilchian, Azadeh, et al.
Publicado: (2020)

Telomere Elongation Frequently Observed during Tumor Metastasis
por: Takada, Toshinori, et al.
Publicado: (1992)

Making Eosinophils Through Subtle Shifts in Transcription Factor Expression
por: McNagny, Kelly, et al.
Publicado: (2002)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Insights Into the Pathologic Roles and Regulation of Eukaryotic Elongation Factor-2 Kinase
por: Ballard, Darby J., et al.
Publicado: (2021)

Control of eukaryotic transcription elongation
por: Winston, Fred
Publicado: (2001)

Lineage specific role of Ship1 in development of allergic airway inflammation
por: Gold, Matthew J, et al.
Publicado: (2014)

Stem cells, inflammation and allergy
por: Blanchet, Marie-Renee, et al.
Publicado: (2009)

ILC-You in the Thymus: A Fresh Look at Innate Lymphoid Cell Development
por: Shin, Samuel B., et al.
Publicado: (2021)

Decreased FENDRR and LincRNA-p21 expression in atherosclerotic plaque
por: Çekin, Nilgün, et al.
Publicado: (2018)

Structural basis for the calmodulin-mediated activation of eukaryotic elongation factor 2 kinase
por: Piserchio, Andrea, et al.
Publicado: (2022)

ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin
por: Piserchio, Andrea, et al.
Publicado: (2023)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells
por: Sanges, C, et al.
Publicado: (2012)

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in ApoE(−/−) Mice
por: Bekkering, Siroon, et al.
Publicado: (2022)

Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer
por: Ng, Tung H., et al.
Publicado: (2019)

Group 2 Innate Lymphoid Cells: Central Players in a Recurring Theme of Repair and Regeneration
por: Messing, Melina, et al.
Publicado: (2020)

Molecular analysis shows the presence of periodontal bacterial DNA in atherosclerotic plaques from patients with coronary artery disease
por: Rao, Amita, et al.
Publicado: (2021)

Association of Chlamydia Pneumoniae Infection With Atherosclerotic Plaque Formation
por: Assar, Omid, et al.
Publicado: (2016)

Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation
por: Li, Hongxia, et al.
Publicado: (2022)

Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation
por: Kondakov, Anton, et al.
Publicado: (2022)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability
por: Chen, Yung‐Chih, et al.
Publicado: (2021)

Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin
por: Schneider-Poetsch, Tilman, et al.
Publicado: (2010)

Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma
por: Russell, Shannon L., et al.
Publicado: (2013)

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
por: Talamonti, Marina, et al.
Publicado: (2023)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques
por: Asada, Yujiro, et al.
Publicado: (2020)

The Fungal Iron Chelator Desferricoprogen Inhibits Atherosclerotic Plaque Formation
por: Potor, László, et al.
Publicado: (2020)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1ucfhv4hdfkc7kfpbc08qh8ud2